(ABBV) AbbVie - Performance 24.3% in 12m
Compare ABBV with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
88.61%
#3 in Group
Rel. Strength
78.36%
#1728 in Universe
Total Return 12m
24.32%
#40 in Group
Total Return 5y
192.53%
#12 in Group
P/E 80.8
95th Percentile in Group
P/E Forward 15.8
58th Percentile in Group
PEG 0.41
78th Percentile in Group
FCF Yield 4.44%
97th Percentile in Group
12m Total Return: ABBV (24.3%) vs XBI (-1.8%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
-1.68% | 29.3% | 171% | 12.1 | 10.6 | 1.43 | 81.5% | 18.5% |
HLN NYSE Haleon |
-0.23% | 21% | 41.1% | 24.4 | 20.2 | 1.79 | 64.4% | 6.58% |
AMGN NASDAQ Amgen |
-6.62% | 9.44% | 46.9% | 37 | 13.4 | 0.94 | -42.0% | -25.9% |
LONN SW Lonza |
8.56% | 16.2% | 38.7% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
BIM PA Biomerieux |
3.94% | 19.8% | 8.84% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
NBIX NASDAQ Neurocrine Biosciences |
-2.63% | -21.7% | 8.36% | 32.4 | 21.5 | 0.27 | 64.4% | 51.8% |
KMDA NASDAQ Kamada |
-2.12% | 27.5% | -10.6% | 26.6 | 24 | 0.96 | 80.4% | 43% |
ERF PA Eurofins Scientific SE |
14% | -1.49% | 17.2% | 26.6 | 13.6 | 0.56 | -67.4% | -17.7% |
Performance Comparison: ABBV vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ABBV
Total Return (including Dividends) | ABBV | XBI | S&P 500 |
---|---|---|---|
1 Month | -6.02% | 2.28% | -0.87% |
3 Months | 7.07% | -10.48% | -7.58% |
12 Months | 24.32% | -1.83% | 11.88% |
5 Years | 192.53% | -12.72% | 110.33% |
Trend Score (consistency of price movement) | ABBV | XBI | S&P 500 |
1 Month | -13.8% | 56.6% | 23% |
3 Months | -22.9% | -89.3% | -88.5% |
12 Months | 58.4% | -42.4% | 55.1% |
5 Years | 94.7% | -53.6% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #145 | -8.12% | -5.20% |
3 Month | #32 | 19.6% | 15.9% |
12 Month | #40 | 26.6% | 11.1% |
5 Years | #10 | 235% | 39.1% |
FAQs
Does ABBV AbbVie outperforms the market?
Yes,
over the last 12 months ABBV made 24.32%, while its related Sector, the SPDR S&P Biotech (XBI) made -1.83%.
Over the last 3 months ABBV made 7.07%, while XBI made -10.48%.
Over the last 3 months ABBV made 7.07%, while XBI made -10.48%.
Performance Comparison ABBV vs Indeces and Sectors
ABBV vs. Indices ABBV is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 6.62% | -5.15% | -0.65% | 12.4% |
US NASDAQ 100 | QQQ | 5.59% | -7.42% | -1.08% | 11.7% |
US Dow Jones Industrial 30 | DIA | 7.56% | -2.84% | -0.56% | 15.1% |
German DAX 40 | DAX | 7.85% | -7.34% | -20.2% | -0.36% |
Shanghai Shenzhen CSI 300 | CSI 300 | 10.6% | -3.20% | 2.34% | 18.4% |
Hongkong Hang Seng | HSI | 7.61% | -6.08% | -2.57% | 10.4% |
India NIFTY 50 | INDA | 9.46% | -10.1% | -0.94% | 21.3% |
Brasil Bovespa | EWZ | 7.42% | -10.6% | -4.35% | 30.1% |
ABBV vs. Sectors ABBV is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 6.37% | -4.97% | -6.78% | 0.36% |
Consumer Discretionary | XLY | 6.54% | -5.92% | -3.16% | 11.0% |
Consumer Staples | XLP | 10.1% | -6.22% | -5.96% | 13.1% |
Energy | XLE | 11.1% | 7.84% | 5.14% | 35.4% |
Financial | XLF | 8.01% | -3.91% | -8.25% | 1.63% |
Health Care | XLV | 6.70% | -2.23% | 1.04% | 22.6% |
Industrial | XLI | 6.20% | -6.13% | -1.36% | 14.7% |
Materials | XLB | 7.23% | -3.59% | 6.76% | 27.8% |
Real Estate | XLRE | 8.14% | -4.71% | 0.24% | 6.23% |
Technology | XLK | 4.17% | -7.71% | 2.69% | 16.6% |
Utilities | XLU | 9.46% | -6.08% | -2.77% | 2.49% |
Aerospace & Defense | XAR | 5.67% | -12.4% | -14.2% | -2.25% |
Biotech | XBI | 5.32% | -8.30% | 12.0% | 26.2% |
Homebuilder | XHB | 7.31% | -3.75% | 14.2% | 31.4% |
Retail | XRT | 8.19% | -5.46% | 4.92% | 27.1% |